Marksans Pharma Limited (MARKSANS.NS) NSE

172.93

-0.62(-0.36%)

Updated at January 14 02:45PM

Currency In INR

Valuation

Market Cap100.57B
Enterprise Value98.83B
P/E Ratio22.23
PEG Ratio42.97
Price/Sales Ratio2.87
Price/Book Ratio2.91
Enterprise/Revenue2.81
Enterprise/EBITDA13.65

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.13
Operating Margin0.22

Management Effectiveness

Return On Assets0.1
Return On Equity0.14

Income Statement

Revenue26.23B
Revenue/Share60.31
Gross Profit14.79B
EBITDA5.29B
Net Income3.81B
Diluted EPS8.4

Balance Sheet

Total Cash6.71B
Total Cash/Share14.83
Total Debt3.32B
Total Debt/Equity0.12
Current Ratio5.18
Book Value Per Share59.93

Price History

52-Week Change-33.04
52-Week High276.4
52-Week Low162
Moving Average 50 Days186.17
Moving Average 200 Days206.11

Statistics

Average Volume843,899
Shares Outstanding453.16M
% Held by Institutions0.14

Dividend And Splits

Trailing Annual Dividend Rate0.8
Trailing Annual Dividend Yield0.46
Payout Ratio0
Last Split Factor10:1
Last Split DateMarch 11, 2008